AMPAkine CX516 alleviated chronic ethanol exposure-induced neurodegeneration and depressive-like behavior in mice
- Toxicol Appl Pharmacol. 2022 Mar 15;439:115924. doi: 10.1016/j.taap.2022.115924.
- 1. Department of Forensic Pathology, School of Forensic Medicine, China Medical University, Shenyang, Liaoning 110122, PR China.
- 2. Department of Thyroid Surgery, the 1st Affiliated Hospital, China Medical University, Shenyang, Liaoning 110001, PR China.
- 3. Department of Forensic Pathology, School of Forensic Medicine, China Medical University, Shenyang, Liaoning 110122, PR China. Electronic address: [email protected].
- 4. Department of Forensic Pathology, School of Forensic Medicine, China Medical University, Shenyang, Liaoning 110122, PR China. Electronic address: [email protected].
Chronic ethanol exposure (CEE) is associated with greater neurodegenerative effects and an increased risk of depression disorder. The AMPAR is thought to be involved in depression and a reduction in its GluA1 subunit was observed in the mouse hippocampus after CEE. AMPAkines are positive allosteric modulators of the AMPA Receptor and have improved depressive-like behavior. However, the role of AMPARs in CEE-induced depressive-like behavior is not clear. It is unclear whether AMPAkines, positive allosteric agonists of AMPARs, protect against ethanol-induced depression. We investigated the effects of CX516 on ethanol-induced depressive-like behavior in a mouse model. CX516 (5 mg/kg) administration alleviated 20% (m/V) ethanol-induced depressive-like behavior in mice. Furthermore, CX516 significantly diminished the inhibition of the ERK1/2-BDNF-TrkB pathway in the hippocampus of ethanol-exposed mice. In addition, CX516 attenuated the levels of pro-inflammatory (IL-6, IL-1β), Apoptosis (Bax, Bcl-2), and neurodegeneration (FJC) in the mouse hippocampus induced by CEE.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: iGluRResearch Areas: Neurological Disease